Abstract:BACKGROUND:A 1996 preproject survey among Canadian Hospital Epidemiology Committee (CHEC) sites revealed variations in the prevention, detection, management and surveillance ofClostridium difficile-associated diarrhea (CDAD). Facilities wanted to establish national rates of nosocomially acquired CDAD (N-CDAD) to understand the impact of control or prevention measures, and the burden of N-CDAD on health care resources. The CHEC, in collaboration with the Laboratory Centre for Disease Control (Health Canada) and… Show more
“…The rates are remarkably similar to those found in our previous study [7]; however, we found wide variations in HA CDI among the participating hospitals (range, 20-167 cases per 100,000 patients-days). The underlying reasons for this variation remain unclear.…”
The rates are remarkably similar to those found in our previous study; although we found wide variations in HA CDI among the participating hospitals. However, the attributable mortality increased almost 4-fold (5.7% vs. 1.5%; P<.001).
“…The rates are remarkably similar to those found in our previous study [7]; however, we found wide variations in HA CDI among the participating hospitals (range, 20-167 cases per 100,000 patients-days). The underlying reasons for this variation remain unclear.…”
The rates are remarkably similar to those found in our previous study; although we found wide variations in HA CDI among the participating hospitals. However, the attributable mortality increased almost 4-fold (5.7% vs. 1.5%; P<.001).
“…C. difficile vegetative cells produce toxins A and B and hydrolytic enzymes (1). Local production of toxins A and B leads to production of tumour necrosis factor-alpha and proinflammatory interleukins, increased vascular permeability, neutrophil and monocyte recruitment (2), opening of epithelial cell junctions (3) and epithelial cell apoptosis (4). Local production of hydrolytic enzymes leads to connective tissue degradation, leading to colitis, pseudomembrane formation (5) and watery diarrhea.…”
CLOSTRIDIUM DIFFICILE is the most important cause of nosocomial diarrhea in adults. Illness may range from mild watery diarrhea to life-threatening colitis. An antecedent disruption of the normal colonic flora followed by exposure to a toxigenic strain of C. difficile are necessary first steps in the pathogenesis of disease. Diagnosis is based primarily on the detection of C. difficile toxin A or toxin B. First-line treatment is with oral metronidazole therapy. Treatment with oral vancomycin therapy should be reserved for patients who have contraindications or intolerance to metronidazole or who fail to respond to first-line therapy
“…3 There is an overall impression that there has been an increase in the proportion of CDAD cases with severe and fatal complications and an increase in the relapse rate among affected patients. A 1997 Canadian survey 4 indicated that the attributable case-fatality rate to be 1.5%, and other authors have reported an attributable mortality of 0.8 to 2% for nosocomial CDAD.…”
mentioning
confidence: 99%
“…1,2 Studies in the United States and Canada have shown that public-and private-sector policies limiting drug coverage lead to fewer prescriptions being filled, 3,4 higher rates of nursing home admissions 5 and increased use of acute care services. 3 Yet physicians often fail to identify patients who are burdened by high out-of-pocket expenses. 6 Many patients with chronic illnesses who report having underused medications because of cost never discuss this underuse with their physicians.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.